Thromboembolism in Cancer Patients With COVID-19 Infection Compared With Other Infections—A Case Series

Abstract

Abstract An increased risk of venous thromboembolism (VTE) with COVID-19 infection has been well documented, particularly in critically ill-hospitalized patients. The presence of cancer, in addition to several anticancer treatments, can further elevate the risk of VTE. The following case reports describe an increased risk of extensive thrombosis that can be seen with COVID-19 infection in cancer patients. We report 3 cases of pulmonary embolism and deep vein thrombosis in cancer patients with COVID-19 infection. All 3 cases are unique with the timeline of COVID-19 infection and diagnosis of VTE. The current pandemic has alerted the clinician to the potential increased risk for thrombus formation in cancer patients with COVID-19, even days to months after acute infection.